Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines

Beta Drugs Ltd, a growing pharmaceutical company, has announced key regulatory achievements across two international markets. The company secured CPR for two of its brands in the Philippines, enabling commercial distribution, while its manufacturing facility was inspected by Azerbaijan’s Ministry of Health.

Philippines Market Entry

The CPR approvals pave the way for Beta Drugs to expand its footprint in Southeast Asia. With regulatory clearance, the company can now market its products in the Philippines, strengthening its global presence.

Azerbaijan Regulatory Progress

Following a successful facility inspection, Beta Drugs anticipates Good Manufacturing Practice (GMP) approval from Azerbaijan’s Ministry of Health within 1–2 months. This milestone will allow the company to supply medicines to the region, enhancing its international portfolio.

Key Highlights

• CPR received for two brands in the Philippines
• Facility inspected by Azerbaijan’s Ministry of Health
• GMP approval expected within 1–2 months
• Expands global presence in Southeast Asia and Eurasia
• Strengthens regulatory compliance and international growth strategy

Sources: Business Standard, Economic Times, Company Announcements